Skip to main
PATH

UiPath (PATH) Stock Forecast & Price Target

UiPath (PATH) Analyst Ratings

Based on 13 analyst ratings
Hold
Strong Buy 8%
Buy 0%
Hold 85%
Sell 8%
Strong Sell 0%

Bulls say

UiPath Inc. demonstrates a robust performance with its current remaining performance obligations (cRPO) reaching $820 million, marking a 14% year-over-year increase. The company has also shown impressive total RPO growth of 12% year-over-year, amounting to $1.265 billion, alongside a solid operating income boost attributed to strong licensing revenue from the federal sector. Furthermore, with a gross margin of 84.9% reflecting slight year-over-year improvement and an expected revenue growth of 11.5%, the metrics underline a strong and expanding customer base, evidenced by increases in new customers and notable retention rates.

Bears say

The financial outlook for UiPath Inc appears negative due to declining net revenue retention (NRR), which has decreased to 107% from previous quarters and reflects lower year-over-year growth. The company's non-GAAP operating income, while up from the prior year, remains inconsistent, and adjusted free cash flow has experienced a decline, highlighting potential profitability challenges. Additionally, external factors such as foreign exchange headwinds and the SaaS revenue recognition model further exacerbate concerns regarding revenue growth and margins moving forward.

UiPath (PATH) has been analyzed by 13 analysts, with a consensus rating of Hold. 8% of analysts recommend a Strong Buy, 0% recommend Buy, 85% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UiPath and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UiPath (PATH) Forecast

Analysts have given UiPath (PATH) a Hold based on their latest research and market trends.

According to 13 analysts, UiPath (PATH) has a Hold consensus rating as of Dec 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $15.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $15.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UiPath (PATH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.